Clear Health Pass

Clear Health Pass develops saliva- and fecal-based diagnostic collections. Its work focuses on next-generation diagnostics, genomics, artificial intelligence, deep learning, and collaboration with healthcare researchers. The company describes its aim as making tests accessible and results easier to understand. It also conducts research and development in in-vitro diagnostic testing. Clear Health Pass reports collaborations with clinical laboratories, including high-complexity CLIA labs, CAP-certified CLIA labs, and animal genomics research facilities. Its domestic U.S. laboratory, research, development, and support operations include more than 80 people. The business also reports nearly all of its manufacturing and procurement is U.S.-based. Its stated testing and service focus is helping individuals access diagnostic tests and understand their results.